These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1854874)

  • 1. Is intraperitoneal tobramycin ototoxic in CAPD patients?
    Nikolaidis P; Vas S; Lawson V; Kennedy-Vosu L; Bernard A; Abraham G; Izatt S; Khanna S; Bargman JM; Oreopoulos DG
    Perit Dial Int; 1991; 11(2):156-61. PubMed ID: 1854874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD.
    Tokgoz B; Somdas MA; Ucar C; Kocyigit I; Unal A; Sipahioglu MH; Oymak O; Utas C
    Ren Fail; 2010 Jan; 32(2):179-84. PubMed ID: 20199179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis.
    Tokgoz B; Ucar C; Kocyigit I; Somdas M; Unal A; Vural A; Sipahioglu M; Oymak O; Utas C
    Nephrol Dial Transplant; 2011 Dec; 26(12):4073-8. PubMed ID: 21551083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute peritonitis by temporary discontinuation of dialysis and low doses of oral ciprofloxacin in patients on CAPD.
    Usberti M; Gazzotti RM; Mileti M; Brazzoli A; Zucca F; Depetri G; Braga B; Losio R
    Perit Dial Int; 1994; 14(2):185-6. PubMed ID: 8043679
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin.
    Garinis A; Gleser M; Johns A; Larsen E; Vachhani J
    J Cyst Fibros; 2021 Mar; 20(2):278-283. PubMed ID: 32713806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin and tobramycin in the treatment of CAPD peritonitis.
    Gruer LD; Turney JH; Curley J; Michael J; Adu D
    Nephron; 1985; 41(3):279-82. PubMed ID: 4058628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hearing thresholds in CAPD patients.
    Morton LP; Reynolds L; Zent R; Rayner BL
    Adv Perit Dial; 1992; 8():150-2. PubMed ID: 1361774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: Ototoxicity following tobramycin treatment.
    Harruff EE; Kil J; Ortiz MGT; Dorgan D; Jain R; Poth EA; Fifer RC; Kim YJM; Shoup AG; Flume PA
    J Cyst Fibros; 2021 Mar; 20(2):288-294. PubMed ID: 33341407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice.
    Ogier JM; Lockhart PJ; Burt RA
    Hear Res; 2020 Feb; 386():107870. PubMed ID: 31864009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative ototoxicity of aminoglycoside antibiotics in a guinea pig model (author's transl)].
    Brummett RE
    Nouv Presse Med; 1978 Nov; 7(42):3849-53. PubMed ID: 568779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin.
    van der Hulst RJ; Boeschoten EW; Nielsen FW; Struijk DG; Dreschler WD; Tange RA
    ORL J Otorhinolaryngol Relat Spec; 1991; 53(1):19-22. PubMed ID: 2008289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Protective Effect of N-Acetylcysteine against Amikacin-Induced Ototoxicity in End-Stage Renal Disease: A Randomized Trial.
    Vural A; Koçyiğit İ; Şan F; Eroğlu E; Ketenci İ; Ünal A; Tokgöz B; Ünlü Y
    Perit Dial Int; 2018; 38(1):57-62. PubMed ID: 29097487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
    Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vestibular toxicity due to gentamicin in peritoneal dialysis patients.
    Chong TK; Piraino B; Bernardini J
    Perit Dial Int; 1991; 11(2):152-5. PubMed ID: 1854873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: teicoplanin plus tobramycin versus cephalothin plus tobramycin.
    Lupo A; Rugiu C; Bernich P; Laudon A; Marcantoni C; Mosconi G; Cantaluppi MC; Maschio G
    J Antimicrob Chemother; 1997 Nov; 40(5):729-32. PubMed ID: 9421325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD.
    Vargemezis V; Thodis E; Pasadakis P; Martinis G; Kousta E
    Adv Perit Dial; 1990; 6():123-5. PubMed ID: 1982788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobramycin kinetics during continuous ambulatory peritoneal dialysis.
    Bunke CM; Aronoff GR; Brier ME; Sloan RS; Luft FC
    Clin Pharmacol Ther; 1983 Jul; 34(1):110-6. PubMed ID: 6861432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin administration in continuous ambulatory peritoneal dialysis: the risk of ototoxicity.
    Gendeh BS; Gibb AG; Aziz NS; Kong N; Zahir ZM
    Otolaryngol Head Neck Surg; 1998 Apr; 118(4):551-8. PubMed ID: 9560111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitis.
    Selgas R; Muñoz J; Cigarran S; Ramos P; L-Revuelta K; Escuin F; Miguel JL
    Perit Dial Int; 1989; 9(4):329-32. PubMed ID: 2577360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.